St. Jude Medical

Amended 483 issued July 6, 2015 · Atlanta, Georgia

Inspection
Jun 9 – Jul 6, 2015
Observations
12
Pages
16
FEI number
3004936110

In short: On July 6, 2015, FDA issued a Amended 483 with 12 observations to St. Jude Medical in Atlanta, Georgia (FEI 3004936110) after an inspection that ran Jun 9 – Jul 6, 2015. The investigators were Claudette D. Brooks and Miaja Umaedi. Most observations concern cAPA and production & process controls; the most-cited regulation is 21 CFR 820.100 (corrective and preventive action).

At a glance

CAPA and production & process controls account for 8 of 12 observations.

CAPA4
Production & process controls4
Management controls2
Records & documents1
Other1

Most cited: 21 CFR 820.22 (2×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    An MDR report was not submitted within 30 days of receiving or otherwise becoming aware of…

  2. 02

    Corrective and preventive action activities and/or results have…

  3. 03

    Process validation activities have not…

  4. 04

    Production processes were not developed, conducted, controlled, and monitored to ensure that a device…

8 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full amended 483

This inspection in context

Questions about this amended 483

What did FDA find at St. Jude Medical?

FDA listed 12 observations on this Form 483, mostly about cAPA, production & process controls and management controls. The most-cited regulation is 21 CFR 820.100 (corrective and preventive action). The opening words of each observation are shown on this page.

Who inspected St. Jude Medical?

Claudette D. Brooks and Miaja Umaedi are named on this Amended 483, for the inspection of Jun 9 – Jul 6, 2015. Each investigator has a profile showing what they cite most.

When was St. Jude Medical inspected by FDA?

The inspection ran Jun 9 – Jul 6, 2015, and the Amended 483 is dated July 6, 2015.

How do I get the full Amended 483 for St. Jude Medical?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free